Literature DB >> 20537870

Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.

Waseem Kaialy1, Mohammed N Momin, Martyn D Ticehurst, John Murphy, Ali Nokhodchi.   

Abstract

In this research mannitol particles were prepared by recrystallisation using non-solvent precipitation technique to investigate the effect of engineered carrier particles on their physicochemical properties and the in vitro deposition profiles of a model drug (salbutamol sulphate (SS)) from a dry powder inhaler (DPI). To this end, mannitol aqueous solution (15%, w/v) was added to different ratios of ethanol:water (100:0, 95:5, 90:10 and 85:15) to obtain mannitol particles. These crystallised mannitol particles were analysed in terms of micromeritic properties, morphology, DSC, FT-IR, and in vitro fine particle fraction (FPF) and emitted dose (ED) of SS. The results showed that the elongation ratio of all the recrystallised mannitol batches was higher than the original material giving them a needle-shaped morphology. Salbutamol sulphate deposition profiles from DPI formulation containing recrystallised needle-shaped mannitol showed enhanced performance and better delivery to the lower MSLI stages. The FPF increased from 15.4+/-1.1 to 45.8+/-0.7% when the commercial mannitol was replaced by mannitol crystallised from ethanol:water (90:10). This improvement could be due to the presence of elongated mannitol crystals in formulation blends. Solid state characterisation of engineered mannitol showed that the commercial mannitol was beta-form, mannitol recrystallised from ethanol:water (85:15) was alpha-form and that samples recrystallised in presence of pure ethanol or other ratios of ethanol:water (95:5 and 90:10) were the mixtures of alpha-, beta- and delta-forms. Multi-solvent recrystallisation technique was proved to have potential to produce mannitol crystals suitable for enhanced aerosolisation efficiency. Comparing different crystallised mannitol formulations showed that the final form (the type of polymorph) of the crystallised mannitol does not have a substantial effect on salbutamol sulphate aerosolisation performance. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537870     DOI: 10.1016/j.colsurfb.2010.04.016

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  11 in total

1.  Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  AAPS J       Date:  2013-04-17       Impact factor: 4.009

2.  The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.

Authors:  Waseem Kaialy; Hassan Larhrib; Gary P Martin; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

3.  Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.

Authors:  Waseem Kaialy; Gary P Martin; Martyn D Ticehurst; Paul Royall; Mohammad A Mohammad; John Murphy; Ali Nokhodchi
Journal:  AAPS J       Date:  2010-11-06       Impact factor: 4.009

4.  Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

5.  Investigation into alternative sugars as potential carriers for dry powder formulation of budesonide.

Authors:  Mohammed-Nurul Momin; Atoosa Hedayati; Ali Nokhodchi
Journal:  Bioimpacts       Date:  2011-08-05

6.  Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.

Authors:  Waseem Kaialy; Tariq Hussain; Amjad Alhalaweh; Ali Nokhodchi
Journal:  Pharm Res       Date:  2013-08-06       Impact factor: 4.200

7.  The effect of solvent treatment on the performance of various carriers in dry powder inhalations containing salbutamol sulphate.

Authors:  Mohammad Reza Siahai Shadbad; Leonie Millen; Mn Momin; Ali Nokhodchi
Journal:  Iran J Basic Med Sci       Date:  2013-07       Impact factor: 2.699

8.  Evidence-based nanoscopic and molecular framework for excipient functionality in compressed orally disintegrating tablets.

Authors:  Ali Al-Khattawi; Hamad Alyami; Bill Townsend; Xianghong Ma; Afzal R Mohammed
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

Review 9.  Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2018-01-14

10.  Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.

Authors:  Carlos Molina; Waseem Kaialy; Qiao Chen; Daniel Commandeur; Ali Nokhodchi
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.